2013-03-19 07:01:55 -
Oslo, Norway, 19 March 2013 - Algeta ASA (OSE: ALGETA), a company focused on the
development of novel targeted cancer therapeutics, announces its Annual General
Meeting 2013:
Algeta's Annual General Meeting will be held on 11 April 2013 at 16:00 hours
(CET) at the offices of Algeta ASA at Kjelsåsveien 172A, Oslo, Norway.
Please find attached the Notice of Algeta ASA's Annual General Meeting, proposed
amended charter for the nomination committee, and attendance slip and proxy
form. These are, together with the annual report, also available on
www.algeta.com in the Investor section.
###
For further information, please contact:
Mike Booth / Renate Birkeli +47 23 00 67 32
Communications & Corporate Affairs
ir@algeta.com
Media enquiries:
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson
mark.swallow@citigatedr.co.uk
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton
knut.ekern@hkstrategies.com
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications
kwatson@macbiocom.com
US investor enquiries:
Tricia Swanson +1 646 378 2953
The Trout Group
tswanson@troutgroup.com
About Algeta
Algeta is a company focused on developing novel targeted therapies for patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in
Cambridge, MA performing commercial marketing operations in the US. Algeta is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please
visit www.algeta.com.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Proposed amended charter for the Nomination Committee:
hugin.info/134655/R/1686052/552590.pdf
Attendance and proxy form:
hugin.info/134655/R/1686052/552589.pdf
Notice of Attendance of Annual General Meeting in Algeta ASA:
hugin.info/134655/R/1686052/552588.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE
[HUG#1686052]